MPM ONCOLOGY INNOVATIONS FUND LP - Insider Non-Derivative Transactions at Werewolf Therapeutics, Inc. (HOWL) - (SEC)

Updated on March 12, 2026.

According to recent SEC insider information filed on Nov 3, 2025, MPM ONCOLOGY INNOVATIONS FUND LP's relationship to Werewolf Therapeutics, Inc. (HOWL) is TenPercentOwner, and currently has 6,147,610 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other HOWL insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

MPM ONCOLOGY INNOVATIONS FUND LP - Insider Non-Derivative Transactions of HOWL Common Stock

MPM ONCOLOGY INNOVATIONS FUND LP - Insider Non-Derivative Transactions at HOWL

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Nov 4, 2025	Sell -- (Common Stock)	94063	1.29	6147610
Nov 1, 2025	Sell -- (Common Stock)	114044	1.28	6241673
Oct 31, 2025	Sell -- (Common Stock)	86936	1.43	6355717